RayzeBio, Inc. Common Stock
RYZB · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$69 | -$29 | -$7 |
| Dep. & Amort. | $2 | $0 | $0 |
| Deferred Tax | -$0 | $1 | $0 |
| Stock-Based Comp. | $6 | $2 | $0 |
| Change in WC | $3 | $1 | $0 |
| Other Non-Cash | $7 | -$7 | $4 |
| Operating Cash Flow | -$52 | -$31 | -$2 |
| Investing Activities | – | – | – |
| PP&E Inv. | -$9 | -$6 | -$0 |
| Net Acquisitions | $0 | $0 | $0 |
| Inv. Purchases | -$147 | -$191 | -$3 |
| Inv. Sales/Matur. | $129 | $43 | $0 |
| Other Inv. Act. | $0 | -$19 | $0 |
| Investing Cash Flow | -$27 | -$171 | -$4 |
| Financing Activities | – | – | – |
| Debt Repay. | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 |
| Stock Repurch. | -$2 | -$0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | $158 | $110 | $150 |
| Financing Cash Flow | $158 | $110 | $150 |
| Forex Effect | $0 | $0 | $0 |
| Net Chg. in Cash | $79 | -$93 | $144 |
| Supplemental Information | – | – | – |
| Beg. Cash | $51 | $144 | $0 |
| End Cash | $129 | $51 | $144 |
| Free Cash Flow | -$61 | -$37 | -$3 |